Nisa Investment Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Nisa Investment Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-325	Closed	-$6K	–	1928
2018 Q1	$6K	Buy	+325	New	+$6.38K	﹤0.01%	1787
2017 Q1	–	Sell	-5,000	Closed	-$66K	–	1925
2016 Q4	$66K	Sell	5,000 -800	-14%	-$13.7K	﹤0.01%	1398
2016 Q3	$137K	Buy	5,800 +5,000	+625%	+$134K	﹤0.01%	1294
2016 Q2	$23K	Hold	800	–	–	﹤0.01%	1577
2016 Q1	$26K	Buy	+800	New	+$28.1K	﹤0.01%	1532
2015 Q3	–	Sell	-25,800	Closed	-$1.19M	–	1323
2015 Q2	$1.19M	Buy	+25,800	New	+$1.22M	0.02%	719
2014 Q1	–	Sell	-12,000	Closed	-$302K	–	1351
2013 Q4	$302K	Buy	+12,000	New	+$268K	﹤0.01%	1169

Nisa Investment Advisors's IPXL Position: Q2 2018 in Review

Nisa Investment Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 325 shares — an estimated $6K sold.

Nisa Investment Advisors first reported a position in IPXL in Q4 2013 and held it in 7 quarters. The position peaked at $1.19M in Q2 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Nisa Investment Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Nisa Investment Advisors sold 325 Impax Laboratories, Inc. shares in Q2 2018, an estimated $6K.
Nisa Investment Advisors first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 7 quarters.
Nisa Investment Advisors's Impax Laboratories, Inc. position peaked at $1.19M in Q2 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Nisa Investment Advisors's 13F filing for Q2 2018, filed 19 Jul 2018.